Longying Jiang

1.7k total citations · 2 hit papers
37 papers, 1.3k citations indexed

About

Longying Jiang is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Longying Jiang has authored 37 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Oncology and 5 papers in Hepatology. Recurrent topics in Longying Jiang's work include Fibroblast Growth Factor Research (6 papers), FOXO transcription factor regulation (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Longying Jiang is often cited by papers focused on Fibroblast Growth Factor Research (6 papers), FOXO transcription factor regulation (4 papers) and Drug Transport and Resistance Mechanisms (4 papers). Longying Jiang collaborates with scholars based in China, United States and United Kingdom. Longying Jiang's co-authors include Yongheng Chen, Hudie Wei, Lingzhi Qu, Shuyan Dai, Huajun Zhang, Wuyang Zhang, Zhuchu Chen, Desheng Xiao, Huajun Zhang and Ming Guo and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Longying Jiang

37 papers receiving 1.3k citations

Hit Papers

Farnesoid X receptor (FXR): Structures and ligands 2021 2026 2022 2024 2021 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Longying Jiang China 18 549 305 210 205 163 37 1.3k
Ling Shuai China 21 872 1.6× 100 0.3× 178 0.8× 142 0.7× 148 0.9× 75 1.2k
Yi Lü United States 23 933 1.7× 349 1.1× 305 1.5× 43 0.2× 85 0.5× 68 1.6k
Jing Jiang China 19 577 1.1× 224 0.7× 42 0.2× 62 0.3× 155 1.0× 68 1.5k
Baohong Zhang China 24 579 1.1× 305 1.0× 113 0.5× 32 0.2× 161 1.0× 77 1.6k
Hisashi Hisatomi Japan 19 713 1.3× 171 0.6× 114 0.5× 44 0.2× 86 0.5× 62 1.2k
Jung‐Hwa Oh South Korea 21 866 1.6× 223 0.7× 166 0.8× 32 0.2× 82 0.5× 69 1.4k
Weidan Ji China 19 945 1.7× 252 0.8× 105 0.5× 45 0.2× 74 0.5× 32 1.3k
Kee-Ho Lee South Korea 20 855 1.6× 246 0.8× 116 0.6× 68 0.3× 45 0.3× 48 1.4k
Jing Ni China 19 654 1.2× 165 0.5× 87 0.4× 52 0.3× 74 0.5× 66 1.2k

Countries citing papers authored by Longying Jiang

Since Specialization
Citations

This map shows the geographic impact of Longying Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longying Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longying Jiang more than expected).

Fields of papers citing papers by Longying Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longying Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longying Jiang. The network helps show where Longying Jiang may publish in the future.

Co-authorship network of co-authors of Longying Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Longying Jiang. A scholar is included among the top collaborators of Longying Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longying Jiang. Longying Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Longying, Xujun Liang, Shuyan Dai, et al.. (2024). Structural characterization of the DNA binding mechanism of retinoic acid-related orphan receptor gamma. Structure. 32(4). 467–475.e3. 2 indexed citations
2.
Li, Hui‐Liang, Shuyan Dai, Lingzhi Qu, et al.. (2024). Design, synthesis, and biological evaluation of selective covalent inhibitors of FGFR4. European Journal of Medicinal Chemistry. 268. 116281–116281. 4 indexed citations
3.
Liang, Xujun, Ming Guo, Longying Jiang, et al.. (2024). Predicting miRNA–Disease Associations by Combining Graph and Hypergraph Convolutional Network. Interdisciplinary Sciences Computational Life Sciences. 16(2). 289–303. 10 indexed citations
4.
Wei, Hudie, Haolan Wang, Lingzhi Qu, et al.. (2023). Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity. Nature Communications. 14(1). 4300–4300. 58 indexed citations
5.
Qu, Lingzhi, Xiaojuan Chen, Hudie Wei, et al.. (2022). Structural insights into the potency and selectivity of covalent pan-FGFR inhibitors. Communications Chemistry. 5(1). 5–5. 17 indexed citations
6.
Jiang, Longying, Hudie Wei, Shuyan Dai, et al.. (2022). Structural insight into the molecular mechanism of cilofexor binding to the farnesoid X receptor. Biochemical and Biophysical Research Communications. 595. 1–6. 5 indexed citations
7.
Qu, Lingzhi, Ming Guo, Huajun Zhang, et al.. (2022). Characterization of the modification of Kelch-like ECH-associated protein 1 by different fumarates. Biochemical and Biophysical Research Communications. 605. 9–15. 7 indexed citations
8.
Dai, Shuyan, Lingzhi Qu, Jun Li, et al.. (2022). Structural insight into the ligand binding mechanism of aryl hydrocarbon receptor. Nature Communications. 13(1). 6234–6234. 37 indexed citations
9.
Guo, Ming, Shuyan Dai, ­Jun Li­, et al.. (2022). Structural study of ponatinib in inhibiting SRC kinase. Biochemical and Biophysical Research Communications. 598. 15–19. 10 indexed citations
10.
Chen, Xiaojuan, Hui‐Liang Li, Shuyan Dai, et al.. (2022). Structure-based design of a dual-warhead covalent inhibitor of FGFR4. Communications Chemistry. 5(1). 36–36. 13 indexed citations
12.
Wei, Hudie, Lingzhi Qu, Shuyan Dai, et al.. (2021). Structural insight into the molecular mechanism of p53-mediated mitochondrial apoptosis. Nature Communications. 12(1). 2280–2280. 76 indexed citations
13.
Jiang, Longying, Desheng Xiao, Yubin Li, et al.. (2020). Structural basis of tropifexor as a potent and selective agonist of farnesoid X receptor. Biochemical and Biophysical Research Communications. 534. 1047–1052. 18 indexed citations
14.
Guo, Ming, Shuyan Dai, Daichao Wu, et al.. (2020). Characterization of ibrutinib as a non-covalent inhibitor of SRC-family kinases. Bioorganic & Medicinal Chemistry Letters. 34. 127757–127757. 10 indexed citations
15.
Jiang, Longying, Shuyan Dai, Jun Li, et al.. (2019). Structural basis of binding of homodimers of the nuclear receptor NR4A2 to selective Nur-responsive DNA elements. Journal of Biological Chemistry. 294(51). 19795–19803. 25 indexed citations
16.
Jiang, Longying, Hudie Wei, Ningning Yan, et al.. (2019). Structural basis of NR4A1 bound to the human pituitary proopiomelanocortin gene promoter. Biochemical and Biophysical Research Communications. 523(1). 1–5. 7 indexed citations
17.
Li, Jun, Longying Jiang, Xujun Liang, et al.. (2017). DNA-binding properties of FOXP3 transcription factor. Acta Biochimica et Biophysica Sinica. 49(9). 792–799. 16 indexed citations
18.
Wu, Daichao, Lingzhi Qu, Yang Fu, et al.. (2016). Expression and purification of the kinase domain of PINK1 in Pichia pastoris. Protein Expression and Purification. 128. 67–72. 4 indexed citations
19.
Chen, Ji‐Hong, Qian Zhang, Yuanjie Yu, et al.. (2013). Neurogenic and Myogenic Properties of Pan-Colonic Motor Patterns and Their Spatiotemporal Organization in Rats. PLoS ONE. 8(4). e60474–e60474. 51 indexed citations
20.
Jiang, Longying, et al.. (2011). Preparation and Structure of a New Coagulation Factor XI Catalytic Domain for Drug Discovery. Chinese Journal of Structural Chemistry. 30(7). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026